AAAAAA

   
Results: 1-13 |
Results: 13
Dyslipidaemia in patients with malignant-phase hypertension
Authors: Edmunds, E Landray, MJ Li-Saw-Hee, FL Hughes, BA Beevers, DG Lip, GYH
Citation: E. Edmunds et al., Dyslipidaemia in patients with malignant-phase hypertension, QJM-MON J A, 94(6), 2001, pp. 327-332
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patientswith coronary artery disease
Authors: Thambyrajah, J Landray, MJ Jones, HJ McGlynn, FJ Wheeler, DC Townend, JN
Citation: J. Thambyrajah et al., A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patientswith coronary artery disease, J AM COL C, 37(7), 2001, pp. 1858-1863
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment
Authors: Landray, MJ Thambyrajah, J McGlynn, FJ Jones, HJ Baigent, C Kendall, MJ Townend, JN Wheeler, DC
Citation: Mj. Landray et al., Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment, AM J KIDNEY, 38(3), 2001, pp. 537-546
Abnormalities of endothelial function in patients with predialysis renal failure
Authors: Thambyrajah, J Landray, MJ McGlynn, FJ Jones, HJ Wheeler, DC Townend, JN
Citation: J. Thambyrajah et al., Abnormalities of endothelial function in patients with predialysis renal failure, HEART, 83(2), 2000, pp. 205-209
Predicting left ventricular systolic dysfunction - Reply
Authors: Landray, MJ Lehman, R Arnold, I
Citation: Mj. Landray et al., Predicting left ventricular systolic dysfunction - Reply, BR MED J, 321(7265), 2000, pp. 895-896
Measuring brain natriuretic peptide in suspected left ventricular systolicdysfunction in general practice: cross-sectional study
Authors: Landray, MJ Lehman, R Arnold, I
Citation: Mj. Landray et al., Measuring brain natriuretic peptide in suspected left ventricular systolicdysfunction in general practice: cross-sectional study, BR MED J, 320(7240), 2000, pp. 985-986
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction
Authors: Lip, GYH Lydakis, C Nuttall, SL Landray, MJ Watson, RDS Blann, AD
Citation: Gyh. Lip et al., A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction, J INTERN M, 248(4), 2000, pp. 316-318
Sudden death: ACE inhibitors and beta-blockers
Authors: Landray, MJ
Citation: Mj. Landray, Sudden death: ACE inhibitors and beta-blockers, BAS R CARD, 95, 2000, pp. 37-40
Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
Authors: Thambyrajah, J Landray, MJ McGlynn, FJ Jones, HJ Wheeler, DC Townend, JN
Citation: J. Thambyrajah et al., Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?, CIRCULATION, 102(8), 2000, pp. 871-875
White coat hypertension: a recognised syndrome with uncertain implications
Authors: Landray, MJ Lip, GYH
Citation: Mj. Landray et Gyh. Lip, White coat hypertension: a recognised syndrome with uncertain implications, J HUM HYPER, 13(1), 1999, pp. 5-8
White coat hypertension and carotid atherosclerosis
Authors: Landray, MJ Sagar, G Murray, S Beevers, M Beevers, DG Lip, GYH
Citation: Mj. Landray et al., White coat hypertension and carotid atherosclerosis, BLOOD PRESS, 8(3), 1999, pp. 134-140
Lipid-lowering drugs and homocysteine
Authors: Landray, MJ Townend, JN Martin, S Martin, U Wheeler, DC
Citation: Mj. Landray et al., Lipid-lowering drugs and homocysteine, LANCET, 353(9168), 1999, pp. 1974-1975
Effect of atorvastatin on low-density lipoprotein subfraction profile
Authors: Landray, MJ Hartland, A Hubscher, D Kendall, MJ Cramb, R
Citation: Mj. Landray et al., Effect of atorvastatin on low-density lipoprotein subfraction profile, ANN CLIN BI, 36, 1999, pp. 240-241
Risultati: 1-13 |